Funding Opportunity: PAR-20-254 Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)

Having trouble viewing this email? View it as a Web page.

Updates

Funding Opportunity Announcement: Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)

The National Institute on Minority Health and Health Disparities (NIMHD) is partnering with several other Institutes and Centers at the National Institutes of Health to support a new funding opportunity announcement (FOA): PAR-20-254. The FOA is titled: Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional).

NIMHD is interested in supporting research that will advance the use of self-identified race and ethnicity (SIRE), and ancestry informative markers (AIMs) to enhance the description of research participants' diverse backgrounds and experiences in scientifically and socially meaningful ways in genomic research, genomic health care, and the broader societal, legal and social arenas. NIMHD is also interested in supporting research that will advance the creation of guidelines and the adoption of consensus practices for applying race, ethnicity, social determinants of health, and ancestry data in study design, result interpretation, publications, and medical care.

The research must focus on one or more U.S. minority or health disparity populations, and may use available secondary data, health system data and/or collection of primary data.

First Due Date of Application: September 19, 2020

For inquiries related to NIMHD’s scientific and research involvement concerning this FOA, please contact Dr. Nancy Jones at nancy.jones@nih.gov. View the full funding opportunity announcement for more information.

Learn More